Designing the Sisaket Telepharmacy Network Application
Main Article Content
Abstract
Objective: To develop an application for providing telepharmacy services by the network of hospital and “heartwarming community pharmacies” in Sisaket Province (the Application) Method: This study was an action research by conducting in-depth interviews with recipients of telepharmacy service to collect information on needs, problems and opinions towards the system of telepharmacy services. The obtained information was input in focus group discussions with the application development team consisting of 6 pharmacists at Sisaket Hospital and one community pharmacist. Results: The requirement of the Application among service recipients and those in the application development team included the following features: system of the Application should enable drug counseling before and after provision of telepharmacy services to patients by hospital pharmacists and community pharmacists in the network; the Application could be used to contact the service recipient in order to monitor drug use problems, side effects of medications and to record and update all service recipients' information; the Application should be secured by solely granting permission to access information for pharmacists providing telepharmacy services of Sisaket Hospital and community pharmacists in the network. Conclusion: The developed application has features meeting the needs of service clients and pharmacists providing telepharmacy services. It can be used as a tool to transmit information between those within Sisaket telepharmacy network and to monitor drug safety among telepharmacy recipients which could facilitate service provision. The Application could help expand professional role of community pharmacists as well as reduce the workload of hospital pharmacists.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Pharmacy Council. Telepharmacy: Guideline [online]. 2020 [cited May 28, 2023]. Available form pharmacy council.org/share/file/file_5928.telepharmacy62-2565 Telepharmacy.PDF.
Limpananont J, kittiwongsoontorn W, Sakulbamroong sin R, Thantayothin W, Sripanitchakulchai K, Kessom boon N, et al. Development of telepharmacy practice guideline in Thailand. Bangkok. Health Systems Research Institute; 2021. p. 103-07.
Alexander E, Butler CD, Darr A, Jenkins MT, Long RD, Shipman CJ, et al. ASHP statement on telephar- macy [online]. 2017 [cited Oct 3, 2022]. Available form academic.oup.com/ajhp/articleabstract/74/9/e23 6/5102780?redirectedFrom= fulltext.
National Association of Boards of Pharmacy. The Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy.J Pharm Pract 1995; 8: 92-8. doi:10.1177/0897190095008003 02.
Canadian Society of Hospital Pharmacists. Telephar- macy guidelines 2018 [online]. 2018 [cited Oct 3, 2022]. Available form www.telemedecine-360.com /wp-content/uploads/2019/03/2018 CSHP-Telephar macy-Guidelines.pdf.
Singapore Pharmacy Council: Pharmaceutical Society of Singapore guidelines telepharmacy 2009 [online]. 2009 [cited Aug 19, 2022]. Available form www.pss.org.sg/sites/default/files/Guidelines/guidelines_for_telepharmacy.pdf.
Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: Innovative strategies for clinical pharma- cists. Res Social Adm Pharm 2021; 17: 1813–18.
Asseri A, Manna M, Yasin I, Moustafa M, Roubie G, El-Anssay S, et al. Implementation and evaluation of telepharmacy during COVID-19 pandemic in an academic medical city in the Kingdom of Saudi Arabia : Paving the way for telepharmacy. World J Adv Res Rev 2020; 7: 218–26.
Sangchan P, Thananithisak C. The application deve- lopment for smoking cessation services by community pharmacists. Srinagarind Medical Journal 2018; 33: 169-75.
Crosby LE, Ware RE, Goldstein A, Walton A, Joffe NE, Vogel C, Britto MT. Development and evaluation of iManage: A self-management app co-designed by adolescents with sickle cell disease. Pediatr Blood Cancer 2017; 64: 139-45.
Hightow-Weidman L, Muessig K, Knudtson K, Sri- vatsa M, Lawrence E, LeGrand S, Hotten A, Hosek S. A gamified smartphone app to support engage ment in care and medication adherence for HIV-positive young men who have sex with men (AllyQuest): Development and pilot study. JMIR Public Health Surveill 2018; 4: e34. doi: 10.2196/pub lichealth.8923.
Habib B, Buckeridge D, Bustillo M, Marquez SN, Thakur M, Tran T, Weir DL, Tamblyn R. Smart About Meds (SAM): a pilot randomized controlled trial of a mobile application to improve medication adherence following hospital discharge. JAMIA Open 2021; 4: ooab050. doi: 10.1093/jamiaopen/ooab050.
Moltó-Puigmartí C, Vonk R, van Ommeren G, Hegger I. A logic model for pharmaceutical care. J Health Serv Res Policy 2018; 23: 148-57. doi: 10.11 77/1355819618768343.
Tan EC, Stewart K, Elliott RA, George J. Pharmacist consultations in general practice clinics: the Pharma- cists in Practice Study (PIPS). Res Social Adm Pharm 2014; 10: 623-32. doi:10.1016/j.sapharm.2013.08.005
Pakdeewattanakul K, Phanitkul P, Software engineering. Bangkok: KTP Comp and Consult; 1997. p. 187-206.
Assavamekin N. Basic principle of software engi- neering. Bangkok: Se-Ed; 2017. p. 243-70.